Was just re-reading the Galderma announcement. Interesting that it mentioned no "current" member of the board knew about the terminated contract. Hypothetically, if a "former" member of the board knew and didn't disclose I guess that still would leave the company in some trouble? (Although as I said earlier if they hadn't included it in their sales forecasts I wonder if they can contended that the loss of the contract wasn't material and theoretically get them off that problem, if not continuous disclosure).
QIN Price at posting:
29.5¢ Sentiment: Hold Disclosure: Held